Order Article Reprints

André C, Bertaut A, Ladoire S, Desmoulins I, Jankowski C, Beltjens F, Charon-Barra C, Bergeron A, Richard C, Boidot R, et al. HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity. Cancers. 2024; 16(11):2009. https://doi.org/10.3390/cancers16112009

André, Céline, Aurélie Bertaut, Sylvain Ladoire, Isabelle Desmoulins, Clémentine Jankowski, Françoise Beltjens, Céline Charon-Barra, Anthony Bergeron, Corentin Richard, Romain Boidot, and et al. 2024. "HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity" Cancers 16, no. 11: 2009. https://doi.org/10.3390/cancers16112009

André, C., Bertaut, A., Ladoire, S., Desmoulins, I., Jankowski, C., Beltjens, F., Charon-Barra, C., Bergeron, A., Richard, C., Boidot, R., & Arnould, L. (2024). HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity. Cancers, 16(11), 2009. https://doi.org/10.3390/cancers16112009